A selective recruitment of RIPK4low and RIPK4high discrete melanoma cell lineages to the invasive front of melanoma is determined by a differential sensitivity of NF-κB signaling to alternative (PKC-related) activators. The gene discussed is NFKB1; the disease is melanoma.